CJ Biomaterials Names Harry Jang as New Chief Executive Officer
Jang is a 29-year veteran of CJ CheilJedang, holding positions of leadership in countries around the world
- Jang is a 29-year veteran of CJ CheilJedang, holding positions of leadership in countries around the world
Woburn, Massachusetts--(Newsfile Corp. - March 19, 2024) - CJ Biomaterials, Inc, a division of South Korea-based CJ CheilJedang and a primary producer of polyhydroxyalkanoate (PHA) biopolymers, has named Harry Jang as its new Chief Executive Officer. - As the head of CJ Biomaterials, Jang will oversee the company's strategic direction, drive innovation in sustainable materials, and spearhead efforts to expand market presence and partnerships in the global bioplastics industry.
- Jang joined CJ CheilJedang in 1995 and has taken over roles of increasing responsibility at CJ businesses around the world, working in Korea, Brazil, Vietnam, Germany, and most recently, the United States.
- During his tenure, Jang helped CJ BIO America to grow its business, including an expansion of operations at its Ft.